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Abstract
Background: Although the association between metabolic syndrome and intraocular pressure is well known,
the relationship between the intraocular pressure and different combination of the components of metabolic
syndrome has not been actively researched yet. The study aimed to investigate the relationship between the
intraocular pressure and metabolic syndrome components with their different combinations.
Methods: Thirty-one thousand two hundred seventy one healthy people aged 19–79 who attended a
community hospital for a health check-up between January 2011 and December 2013 were enrolled in the
study. Subjects with a history of intraocular disease, at least in one eye and those receiving medical treatment for
glaucoma were excluded. Metabolic syndrome was diagnosed following the criteria defined in Circulation 2009.
Results: Subjects with combination of three metabolic syndrome components of triglycerides, abdominal
obesity, and fasting glucose had the highest intraocular pressure. And subjects with the combination of four
components of blood pressure, high-density lipoproteins, triglycerides, fasting glucose had a significantly
higher intraocular pressure than ones with the combination of all five metabolic syndrome components.
Conclusions: The difference in the risk of high intraocular pressure according to the different combination of
the metabolic syndrome components could be confirmed. If additional follow-up studies are conducted, the
findings can be used as an indicator for predicting intraocular pressure increases in patients with metabolic
syndrome.
Keywords: Blood glucose, Blood pressure, High-density lipoproteins, Intraocular pressure, Metabolic syndrome,
Triglyceride
Background
Glaucoma is a progressive ophthalmic disease that has
the characteristics of optic disc cupping and visual field
defects [1]. A family history of glaucoma, high myopia,
and high intraocular pressure (IOP) are known as risk
factors of glaucoma [2]. Among the various known risk
factors, IOP is considered the most important and
controllable [3–5].
Although the underlying mechanism of increased
IOP is still unclear, a recent study suggested that it
might be associated with various health indices, such
as hypertension, diabetes, and obesity [6–8]. Reaven
[9] indicated that poor health indices, such as abdom-
inal obesity, diabetes, and hypertension, share a single
common mechanism that contributes to insulin resist-
ance and glucose intolerance and therefore gave it the
name “X syndrome”, which has now been changed to
metabolic syndrome (MetS).
The diagnostic criteria for MetS were first announced
in 1998 by the World Health Organization (WHO) [10].
Later, the National Cholesterol Education Program-
Adults Treatment Panel III of the United States pro-
posed MetS criteria that were more clinically applicable
than those announced by the WHO, and these criteria
are widely used [11]. Since then, various organizations
have proposed slightly different criteria in consideration
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of ease in diagnosis, and, recently, in 2009, the Inter-
national Diabetes Federation; National Heart, Lung, and
Blood Institute; American Heart Association; World
Heart Federation; International Atherosclerosis Society;
and International Association for the Study of Obesity
reorganized the various criteria for MetS [12]. Although
many studies have reported on the association between
MetS and IOP, the relationship between MetS compo-
nents and IOP is not well known. With each component
of MetS not independent but correlated, the present
study aimed to identify the correlation of IOP with the
number and combination of MetS components.
Methods
Study subjects
Healthy examinees (31,271) who were between the ages
of 19 to 79 and who attended a health promotion center
in Changwon region of South Korea, between January
2011 and December 2013 were initially considered as
study subjects. Before testing, each participant was inter-
viewed by a trained nurse about previous health prob-
lems and medical history, including ocular diseases. A
written informed consent was obtained from all partici-
pants and participants with a history of intraocular
disease or surgery (in at least in one eye), those receiving
medical treatment for glaucoma, and those who did not
agree to involvement in this study were excluded.
Finally, 28,754 healthy examinees were included in the
present study.
The study protocol complied with the guidelines of
the Declaration of Helsinki and was approved by the
Institutional Review Board of Samsung Changwon




A structured questionnaire survey was conducted
through one-on-one interviews on the subjects’ medical
history, including hypertension, diabetes, dyslipidemia,
and ophthalmological history, by surveyors who had
received annual standardized training on data collection.
Anthropometric measurements
Height was measured to the nearest 0.1 cm by having
the subject face forward with their heels and back of
their head touching the wall, while weight was measured
to the nearest 0.1 kg with an automated scale (GL-150,
G-Tech International Co., Ltd., Seoul, Korea) with the
subject wearing only light clothing. Waist circumference
was measured with the subject positioned in an upright
standing position with their feet together, and a tape
measure was wrapped around the narrowest parts of
the waistline between the ribs and iliac crest. The
measurement was taken at the final stage of the
breathing cycle without pressing the skin.
Clinical examination
Blood pressure (BP) was measured twice with an auto-
matic BP monitor (Jawon Medical Co., Ltd., Seoul,
Korea) while the subject was in a sitting position after
at least 10 min of being stabilized and the two mea-
sured BP values were averaged. If the two measured
values showed a discrepancy ≥ 5 mmHg, one additional
measurement was taken. The subjects were restricted
from smoking or consuming caffeine for 30 min or
more prior to the measurements. Blood samples were
collected intravenously after 8 h or more of fasting, and
a blood test was performed with an enzyme-linked
immunosorbent assay to measure triglyceride (TG),
high-density lipoprotein cholesterol (HDLC), and fast-
ing glucose (Hitachi Modular DPP, Roche Diagnostics
K.K., Tokyo, Japan).
Ophthalmologic examination
The IOP was measured when the subject was in a sitting
position with noncontact tonometry (Topcon CT60,
Topcon Corporation, Tokyo, Japan). The IOP measure-
ments were taken from the central corneal area by an
experienced nurse, and the mean value from three mea-
surements was used. All ophthalmological examinations
were performed between 8 and 11 am to minimize any
effects of diurnal variation, and any IOP ≥22 mmHg
was defined as ocular hypertension.
Diagnostic criteria of MetS
A diagnosis of MetS required the presence of 3 of the 5
diagnostic criteria of MetS listed below [12]. The criteria
for waist circumference was based on the criteria
proposed by the Korean Society for the Study of Obesity
in 2006, which defined abdominal obesity as a waist
circumference of 90 cm or more for males and 85 cm or
more for females [13].
①Abdominal obesity: Male waist circumference ≥
90 cm; Female waist circumference ≥ 85 cm
② Serum TG: ≥150 mg/dL or those taking medication
for its treatment
③HDLC: male < 40 mg/dL, female < 50 mg/dL, or
those taking medication for its treatment
④ BP: ≥130/85 mmHg or those taking medication for
its treatment
⑤ Fasting glucose: ≥100 mg/dL or those taking
medication for its treatment
Statistical analysis
In order to examine the general characteristics of the
study subjects, an independent t-test was used to compare
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the mean values of age, waist circumference, systolic
and diastolic BP, fasting glucose, lipid profiles, and IOP
in the group with IOP ≥22 mmHg and the group with
IOP < 22 mmHg. For comparisons of gender, the pres-
ence of MetS, and components of MetS, a chi-square
test was used for the analysis. For the analysis of the
components of MetS in the group with IOP ≥22
mmHg and the group with IOP < 22 mmHg, a logis-
tic regression analysis was used to obtain the odds
ratio and 95 % confidence interval. All of the statis-
tical analyses were performed with SPSS, ver. 18.0
(IBM Corporation, Armonk, NY, USA).
Results
General characteristics of study subjects
Among the 28,754 study subjects, there were 16,728
males and 12,026 females, with a mean age of
41.26 years. Three thousand five hundred two out of
28,754 exhibited MetS, which was equivalent to a
12.18 % prevalence rate. With respect to gender, males
showed a prevalence rate of 12.65 % (n = 2116), while fe-
males showed a prevalence rate of 11.53 % (n = 1386).
And IOP ≥22 mmHg was found in 991 subjects (3.45 %),
with 799 males (4.78 %) and 192 females (1.60 %)
accounting for the total. A statistically significant differ-
ence in both prevalence rate and IOP value were found
between males and females (P < 0.001) (Fig. 1).
The prevalence of MetS in the group with IOP ≥
22 mmHg and the group with IOP < 22 mmHg was 24.7
and 11.7 %, respectively, which was a significant differ-
ence (P < 0.001; Fig. 2). Moreover, when each of the
mean values for the MetS components was compared
between the group with IOP ≥ 22 mmHg and the group
with IOP < 22 mmHg, all showed a statistically signifi-
cant difference (P < 0.001; Table 1).
Relationship between MetS and IOP
The mean IOP of the right eye in the subjects with MetS
showed higher value of 16.05 mmHg than that of
14.85 mmHg in the subjects without MetS, which
indicated a statistically significant difference(P < 0.001),
while the mean IOP value of the left eye was 16.12 and
14.87 mmHg, respectively.
Among the 3502 subjects with characteristics that
corresponded to MetS, 73.04 % (n = 2558) had three
components of MetS, 23.50 % (n = 823) had four compo-
nents, and 3.46 % (n = 121) had five components.
Moreover, for the cases diagnosed with MetS, the group
with IOP ≥22 mmHg had more components of MetS
than the group with IOP < 22 mmHg (P < 0.001). Having
more components of MetS increased the probability
of having a higher IOP (P for linear trend < 0.001,
Table 2).
Multiple logistic regression analysis adjusted for age
and sex, revealed that the presence of more components
of MetS had a statistically significant higher risk of
increased IOP(P < 0.001, Table 3).
In the group with IOP ≥22 mmHg and three compo-
nents of MetS, the probability of having high IOP was
not significantly different compared to the group with-
out MetS when the criteria for HDLC was included, and
the combination of BP, TG, and fasting glucose criteria
showed the highest odds ratio of 3.73 (P < 0.001,
Table 4).
In the group with IOP ≥22 mmHg and four components
of MetS, only the combination of BP, HDLC, abdominal
obesity, and fasting glucose criteria showed an increased
Fig. 1 Prevalence of metabolic syndrome and ocular hypertension according to gender. Abbreviations: MetS, Metabolic syndrome; IOP, Intraocular
Pressure. P < 0.001 Calculated by chi-square test
Son et al. BMC Ophthalmology  (2016) 16:76 Page 3 of 7
IOP that was not statistically significant compared to
the group without MetS (P = 0.550), while the com-
bination of BP, HDLC, TG, and fasting glucose
criteria showed the higher odds ratio of 9.39 than of
the combination of all five components (P < 0.001,
Table 5).
Discussion
Metabolic syndrome is a type of disease cluster in
which the primary risk factors for cardiovascular dis-
eases, such as hyperglycemia, hypertension, dyslipid-
emia, and abdominal obesity, occur simultaneously, and
many studies have examined this since the WHO
presented the criteria for defining MetS in 1998 [10].
However, even before the concept of MetS was estab-
lished, studies were conducted on the relationships
between factors that comprise MetS and IOP. Many re-
ports have indicated that, in people with obesity, which
is one of the components of MetS, the IOP is increased
because of a decrease in the aqueous humor outflow
due to an increase in orbital fat and episcleral pressure
[14–16]. Moreover, high BP increases the pressure in
the intraocular ciliary artery, which promotes the
formation of the aqueous humor that increases the IOP,
and, hence, the association between IOP and hyperten-
sion has been confirmed in various studies [16, 17].
Higher serum TG, which is one of the two lipid
parameters that comprise MetS, is known to increase
the IOP. Klein et al. [18] indicated that, with higher
serum TG levels, there is a greater amount of orbital
adipose tissue, which causes an increase in orbital
pressure, which causes an increase in IOP by inducing
an increase in episcleral pressure and a decrease in
aqueous humor outflow [19]. Moreover, it has been
reported that higher fat intake and an increased severity
of obesity results in increased TG levels, whereas HLDC,
Fig. 2 Prevalence of metabolic syndrome according to ocular hypertension. Abbreviation: IOP, Intraocular Pressure. P < 0.001 Calculated by
chi-square test
Table 1 General characteristics of the study population
IOP < 22 IOP≥ 22 Pa
Age (years) 41.68 ± 7.47 40.83 ± 7.20 <0.001
Waist circumference (cm) 82.47 ± 8.07 86.23 ± 8.45 <0.001
Systolic blood pressure (mmHg) 122.72 ± 16.22 131.42 ± 16.96 <0.001
Diastolic blood pressure (mmHg) 73.18 ± 11.40 78.36 ± 11.90 <0.001
Fasting glucose (mg/dL) 90.05 ± 15.64 96.78 ± 24.35 <0.001
Triglyceride (mg/dL) 110.27 ± 79.44 146.29 ± 105.67 <0.001
HDL cholesterol (mg/dL) 59.06 ± 14.56 55.52 ± 13.61 <0.001
Left IOP (mmHg) 14.72 ± 2.44 22.18 ± 2.00 <0.001
Right IOP (mmHg) 14.74 ± 2.43 22.15 ± 2.12 <0.001
Abbreviations: IOP intraocular pressure, HDL cholesterol high-density lipoprotein cholesterol
Data are mean ± standard deviation (SD)
aCalculated by independent t-test
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which is another component of MetS, has a low value,
which is the result of increased episcleral pressure and
IOP due to an increase in the vascular sclerosing
changes and serum osmolality [16].
Hyperglycemia has also been reported to be closely
associated with IOP. The continuous fluid inflow into
the eyeball from osmotic pressure that is caused by
hyperglycemia and the autonomic nervous system
dysfunction that is observed in diabetics can induce
increased IOP. Additional studies are needed to find out
their exact mechanism [20–22].
In addition to the worldwide increase in the obese
population, the prevalence of MetS is also showing an
increasing trend, and it was reported that 15–25 % of
Korean adults suffer from MetS [23, 24]. For this reason,
interest in MetS has risen, and many studies on the
association between MetS and IOP have been published
[25–29]. However, up to now, there have been no
reports on the correlation with IOP based on the num-
ber and combination of MetS components.
The present study showed that, even within MetS
group, the presence of more components of MetS was
associated with a higher IOP. As explained earlier, this is
because each MetS component is causing factor of in-
creased IOP. In the group with three components of
MetS, whitch included the criteria for TG, abdominal
obesity, and fasting glucose, the highest risk for IOP in-
creased was shown. In addition, the probability of the
IOP increased was significantly higher in the groups that
satisfied the criteria for BP, TG, and abdominal obesity;
the combination of BP, TG, and fasting glucose criteria;
and the combination of BP, abdominal obesity, and
fasting glucose criteria.
However, all of the cases that had the HDLC criteria
as a component did not have a statistically significant
higher risk of IOP. HDLC itself, as shown in Table 1,
showed significant differences according to the IOP.
However, in the combinations of MetS components, the
effect on IOP was relatively limited and was actually in-
fluenced more by other factors. Such an interpretation
can also be seen in other studies on IOP and lipid
parameters, and many reports indicate that serum TG
and total cholesterol are positively correlated with
IOP, whereas HDLC does not show a corresponding
Table 2 Comparisons of intraocular pressures according to
metabolic syndrome components
MetS components total IOP < 22 IOP≥ 22 Pa
3 2558 2397 161 <0.001
4 823 750 73 <0.001
5 121 110 11 <0.001
Abbreviations: MetS metabolic syndrome, IOP intraocular pressure
aCalculated by chi-square test
P for linear trend < 0.001
Table 3 Association of intraocular pressures with metabolic
syndrome components
MetS components Crude ORa Pa Adjusted ORb Pb
non MetS 1.00 1.00
3 2.21(1.85–2.63) <0.001 2.16(1.81–2.58) <0.001
4 3.20(2.49–4.11) <0.001 3.04(2.35–3.91) <0.001
5 3.29(1.76–6.13) <0.001 3.48(1.85–6.53) <0.001
Abbreviations: MetS metabolic syndrome, OR odds ratio
aCalculated by simple logistic regression analysis
bCalculated by multiple logistic regression analysis adjusted for age and sex
Table 4 Relationship between intraocular pressure and
metabolic parameters in subjects with three components
IOP < 22 IOP ≥ 22 crude ORa Pa
non MetS 24,506 746 1.00
BP + HDL + TG 45 3 2.19 (0.68–7.06) 0.189
BP + HDL +WC 183 9 1.62 (0.82–3.16) 0.163
BP + HDL + DM 7 1 4.69 (0.58–8.19) 0.148
BP + TG +WC 485 35 2.37 (1.67–3.37) <0.001
BP + TG + DM 97 11 3.73 (1.99–6.98) <0.001
BP +WC + DM 441 35 2.61 (1.83–3.71) <0.001
HDL + TG +W 618 23 1.22 (0.38–6.47) 0.351
HDL + TG + DM 42 2 1.56 (0.80–1.89) 0.537
HDL +WC + DM 127 6 1.55 (0.68–-3.53) 0.295
TG +WC + DM 352 36 3.36 (2.37–4.77) <0.001
Abbreviations: IOP intraocular pressure, OR odds ratio, MetS metabolic
syndrome, BP, blood pressure, HDL high-density lipoprotein cholesterol, TG tri-
glyceride, WC waist circumference, DM diabetes mellitus
Definitions of the metabolic syndrome components were as follows: Fasting
glucose ≥ 100 mg/dL (includes diabetes); Blood pressure ≥ 130/85 mmHg or
being treated; Waist circumference, women ≥ 85 cm, men ≥ 90 cm;
Triglyceride ≥ 150 mg/dL or being treated; HDL cholesterol < 50 mg/dL or
being treated
aCalculated by simple logistic regression analysis
Table 5 Relationship between intraocular pressure and metabolic
parameters in subjects with four or five components
IOP < 22 IOP≥ 22 Crude ORa Pa
non MetS 24,506 746 1.00
BP + HDL + TG +WC 230 15 2.14 (1.26–3.63) 0.005
BP + HDL + TG + DM 28 8 9.39 (4.26–20.66) <0.001
BP + HDL +WC + DM 60 1 0.55 (0.08–3.96) 0.550
BP + TG +WC + DM 263 34 4.25 (2.95–6.12) <0.001
HDL + TG +WC + DM 169 15 2.92 (1.71–4.97) <0.001
ALL(five components) 110 11 3.29 (1.76–6.13) <0.001
Abbreviations: IOP intraocular pressure, OR odds ratio, MetS metabolic
syndrome, BP blood pressure, HDL high-density lipoprotein cholesterol,
TG triglyceride, WC waist circumference, DM diabetes mellitus
The definitions of the metabolic syndrome components were as follows:
Fasting glucose ≥ 100 mg/dL (includes diabetes); Blood pressure ≥ 130/
85 mmHg or being treated; Waist circumference, women ≥ 85 cm, men ≥
90 cm; Triglyceride ≥ 150 mg/dL or being treated; HDL cholesterol < 50 mg/dL
or being treated
aCalculated by simple logistic regression analysis
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correlation with IOP. High HDLC is negatively corre-
lated with IOP [17, 30, 31], but one report claims a
positive correlation with IOP as well [16]. A recent
study on Koreans reported a negative correlation
between HDLC and IOP in a multiple regression
analysis that compensated for age, obesity, and BP
[32]. But additional studies appear to be needed to
understand the influence of HDLC on IOP in depth.
In groups with four or more components of MetS, the
group with BP, HDLC, abdominal obesity, and fasting
glucose criteria was the only group that did not show a
significant correlation with IOP increase, and, interest-
ingly, compared to the group with all five components,
the group with BP, HDLC, TG, and fasting glucose
criteria as its components showed the higher risk of IOP
increase. However, whether the IOP increases in MetS
groups are actually different based on their component
combinations is something that requires additional
study, as the number of subjects was too small com-
pared to the entire study population when the groups
were subdivided according to the MetS components.
The genomic variates of subjects could be one of the
factors which cause the IOP increases as well [33].
The present study had a few limitations. First, because
the present study was based on the regular medical
checkup in health promotion center, there was no infor-
mation of cup to disc ratio and visual field analysis. So it
was difficult to investigate the relationship between the
glaucoma and metabolic syndrome components with
their different combinations. Second, we did not meas-
ure central corneal thickness. However, if the IOP that
was adjusted according to the central corneal thickness
was used, it may have been possible to increase the
accuracy. Third, although noncontact tonometers are
reliable for testing within normal IOP ranges, the use of
a Goldmann applanation tonometer would have given
more accurate IOP measurements. Fourth, because the
present study was a cross-sectional study, it was difficult
to identify the causal relationships. Finally, there was no
systemic approach about lifestyle that may have influ-
enced IOP such as smoking history, drinking history,
and the frequency of exercise.
Despite these limitations, this study has significance in
that it showed not only the fact that each component of
MetS is mutually dependent but also the fact that differ-
ent combination of Mets components has correlation
with IOP increase. If additional follow-up studies are
conducted, the findings can be used as an indicator for
predicting IOP increases in patients with MetS.
Conclusions
This study showed that there are the differences in
the risk of high intraocular pressure according to the
different combination of the metabolic syndrome
components. In the group with three components of
MetS, the combination of BP, TG, and fasting glucose
criteria showed the highest risk of intraocular pres-
sure elevation. In the group with four components of
MetS, the combination of BP, HDLC, TG, and fasting
glucose criteria showed the higher risk of intraocular
pressure elevation.
Abbreviations
BP, blood pressure; DM, diabetes mellitus; HDLC, high-density lipoprotein
cholesterol; IOP, intraocular pressure; MetS, metabolic syndrome;
TG, triglyceride; WC, waist circumference; WHO, World Health Organization
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